Induction of potent antitumor immunity by in situ targeting of intratumoral DCs
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Nonstandard abbreviations used: antigen (Ag); bone marrow (BM); CG-rich motif (CpG); complete medium (CM); control oligonucleotide (ODN-CTR); effector/target (E/T); Fms-like thyrosine kinase 3 ligand (Flt3L); Langerhans cell (LC); macrophage inflammatory protein-3α (MIP-3α); mean fluorescence intensity (MFI); T cell receptor (TCR).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A preclinical murine melanoma model showed increased migration of DCs in CCL20‐positive tumor cells, indicating the role of CCL20 in attracting DCs to the tumor site [368].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
T cell receptor antagonist peptides induce positive selection
Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., & Carbone, F. R. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 2,858
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Dieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425
Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., & Bhardwaj, N. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.233 · Cited by 1,359
Induction of tolerance by IL-10-treated dendritic cells
Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4772 · Cited by 1,246
Maraskovsky, E., Brasel, K., Teepe, M., Roux, E. R., Lyman, S. D., Shortman, K., & McKenna, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1953 · Cited by 1,115
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Research works printed but not linked: 3
- Gabrilovich, D.I., Corak, J., Ciernik, I.F., Kavanaugh, D., and Carbone, D.P. 1997. Decreased antigen pre- sentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 3:483-490.
- Nestle, F.O., Burg, G., Fah, J., Wrone-Smith, T., and Nickoloff, B.J. 1997. Human sunlight-induced basal- cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am. J. Pathol. 150:641-651.
- Chen, K., et al. 1997. Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. Cancer Res. 57:3511-3516.
Cited by
Items 201–235 of 235
Diegelmann, J. (2008) · mediaTUM (Technical University of Munich)
Local Immunotherapies of Cancer
Marron, T. U., Hammerich, L., & Brody, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_28
Etude des voies de recrutement des cellules dendritiques dans une tumeur solide
Boulet, D. (2017) · theses.fr (ABES) · doi:10.70675/e4dd9c54zb11fz423ezaddfz0c7f6af1af14
Zhao, H., Chen, C., Chen, X., Yang, C., Zhang, D., Li, Y., Zhao, H., & He, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.646527
RetractedCheckpoint Blockade and Combinatorial Immunotherapies
Peggs, K. S., Quezada, S. A., & Allison, J. P. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8_16
Mi, J. (2005) · OpenGrey (Institut de l'Information Scientifique et Technique)
Using Natural Adjuvants to Stimulate Anti-Tumour Immune Responses
Kuhn, S. P. (2012) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17011490
Moser, M. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1168396.630574
Aspord, C., Leccia, M. ‐., Charles, J., & Plumas, J. (2023) · doi:10.1158/2326-6066.c.6548272.v1
Park, J. L. (2013) · eScholarship (California Digital Library)
Mobilized dendritic cells for lung cancer
University of California Office of the President (2000) · California Digital Library · doi:10.17920/g9px2g
Tu, H.-F., Kung, Y.-J., Lim, L., Tao, J., Hu, M.-H., Cheng, M., Xing, D., Wu, T.-C., & Hung, C.-F. (2024) · Figshare · doi:10.6084/m9.figshare.26674176
Effects of immunomodulatory oligonucleotides on pancreatic cell lines
Rocchi, J. (2009) · Electronic Theses and Dissertations Repository (University of Pisa)
Siachoque, H. O., Ibáñez‐Pinilla, M., Chuaire, L., García, O., Guzmán, A., & Flórez, L. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Combination strategies in the development of oncolytic cancer therapy
Léveillé, S. (2012) · eScholarship@McGill (McGill) · doi:10.82308/24921
The toll-like receptor 9 — from immune cells to cancer. Is TLR9 in tumours a cause or a consequence?
Ishizu, T. (2025) · UTUPub (University of Turku)
Lakomy, D. (2010) · theses.fr (ABES) · doi:10.70675/9b750f15z6e83z4761zb490zacefafe2baab
Utilisation de miRNAs thérapeutiques pour traiter les chondrosarcomes et les ostéosarcomes
Veys, C. (2021) · theses.fr (ABES) · doi:10.70675/7a59188ez7981z4d53za4fdz22a6b5deaaad
Valeri, V., Mion, F., Tonon, S., Martinis, E., Jachetti, E., Sulsenti, R., Capezzali, E., Battista, S., Mangogna, A., Mariuzzi, L., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1725902
Zhao, H., Chen, C., Chen, X., Yang, C., Zhang, D., Li, Y., Zhao, H., & He, J. (2021) · doi:10.3389/fonc.2021.646527.s001
Metadata
- Authors
- Furumoto, K., Soares, L., Engleman, E. G., & Merad, M.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Engleman, Edgar G.
- ORCID
- Engleman, Edgar G.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-03-01
- Volume
- 113
- Issue
- 5
- Pages
- 774-783
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4238827986
- Cited by
- 180
- References
- 43
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 6 · 2014: 4 · 2013: 6 · 2012: 6
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- antitumor immunity, dendritic cells, cancer immunotherapy, Langerhans cells, macrophage inflammatory protein-3α, Flt3 ligand, CpG oligodeoxynucleotides, T cell activation, tumor-associated macrophages
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.